7-Chloro-5-[(2-chlorophenyl)methyl]-2,3,4,5-tetrahydro-1,5-benzothiazepin-4-one

Catalog No. :
ACXWJU386
CAS No. :
341968-08-9
Molecular Formula :
C16H13Cl2NOS
Molecular Weight :
338.26

IUPAC Name:7-chloro-5-(2-chlorobenzyl)-2,3-dihydrobenzo[b][1,4]thiazepin-4(5H)-one

7-Chloro-5-[(2-chlorophenyl)methyl]-2,3,4,5-tetrahydro-1,5-benzothiazepin-4-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name7-Chloro-5-[(2-chlorophenyl)methyl]-2,3,4,5-tetrahydro-1,5-benzothiazepin-4-one
IUPAC Name7-chloro-5-(2-chlorobenzyl)-2,3-dihydrobenzo[b][1,4]thiazepin-4(5H)-one
MDL No.MFCD01569042
Molecular FormulaC16H13Cl2NOS
Molecular Weight338.26
SMILESO=C1CCSC2=CC=C(Cl)C=C2N1CC3=CC=CC=C3Cl
InChI KeyRLACGRKQMLDHHX-UHFFFAOYSA-N
Synonym7-CHLORO-5-(2-CHLOROBENZYL)-2,3-DIHYDRO-1,5-BENZOTHIAZEPIN-4(5H)-ONE;7-chloro-5-[(2-chlorophenyl)methyl]-2,3,4,5-tetrahydro-1,5-benzothiazepin-4-one;1,5-Benzothiazepin-4(5H)-one, 7-chloro-5-[(2-chlorophenyl)methyl]-2,3-dihydro-
CAS No.341968-08-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACXWJU386 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXWJU386 route product structure diagram
    ACXWJU386341968-08-9
Inquiry

2. ACXWJU386 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXWJU386 route product structure diagram
    ACXWJU386341968-08-9
Inquiry

Comments (0)